These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 38814450)
1. Assessing relationship between hospital-acquired functional decline and non-lying time after transcatheter aortic valve implantation in elderly patients: methodological issues. Yanagi H Heart Vessels; 2024 Oct; 39(10):916-917. PubMed ID: 38814450 [No Abstract] [Full Text] [Related]
2. Response to the letter to the editor: clinical impact of non-lying time on hospital-associated functional decline in older patients undergoing transcatheter aortic valve implantation. Kono Y; Mukaino M; Ozawa Y; Mizutani K; Senju Y; Ogasawara T; Yamaguchi M; Muramatu T; Izawa H; Otaka Y Heart Vessels; 2024 Oct; 39(10):918-919. PubMed ID: 38829388 [No Abstract] [Full Text] [Related]
3. Rapid-deployment or transcatheter aortic valves in intermediate-risk patients? Bruno P; Di Cesare A; Nesta M; Cammertoni F; Mazza A; Paraggio L; Rosenhek R; Burzotta F; Crea F; Trani C; Massetti M Asian Cardiovasc Thorac Ann; 2017 May; 25(4):264-270. PubMed ID: 28361580 [TBL] [Abstract][Full Text] [Related]
4. Transcatheter aortic valve implantation: there is still much to know. Tamburino C; Fajadet J EuroIntervention; 2016 Sep; 12(Y):Y21. PubMed ID: 27640025 [No Abstract] [Full Text] [Related]
5. Sutureless versus transcatheter aortic valves in elderly patients with aortic stenosis at intermediate risk: A multi-institutional study. Muneretto C; Solinas M; Folliguet T; Di Bartolomeo R; Repossini A; Laborde F; Rambaldini M; Santarpino G; Di Bacco L; Fischlein T J Thorac Cardiovasc Surg; 2022 Mar; 163(3):925-935.e5. PubMed ID: 32727681 [TBL] [Abstract][Full Text] [Related]
6. Subocclusive Ostial Left Main Disease After Transcatheter Aortic Implantation with Bail-Out Valve-in-Valve. Giordano A; Ferraro P; Biondi-Zoccai G; Corcione N Cardiovasc Revasc Med; 2019 Oct; 20(10):928-930. PubMed ID: 31060968 [No Abstract] [Full Text] [Related]
7. Late degeneration of transcatheter aortic valves: pathogenesis and management. Barbanti M; Tamburino C EuroIntervention; 2016 Sep; 12(Y):Y33-6. PubMed ID: 27640028 [TBL] [Abstract][Full Text] [Related]
13. Cochrane corner: transcatheter aortic valve implantation versus surgical aortic valve replacement for severe aortic stenosis in people with low surgical risk. Kolkailah AA; Doukky R; Pelletier MP; Volgman AS; Kaneko T; Nabhan AF Heart; 2020 Jul; 106(14):1043-1045. PubMed ID: 32482670 [No Abstract] [Full Text] [Related]
14. Transcatheter Aortic Valve Replacement in Intermediate- and Low-Risk Patients. Rogers T; Thourani VH; Waksman R J Am Heart Assoc; 2018 May; 7(10):. PubMed ID: 29754127 [No Abstract] [Full Text] [Related]
15. Will transcatheter aortic valve implantation represent the choice treatment for all patients who need a biological valve? Spaccarotella C; Mongiardo A; Curcio A; De Rosa S; Indolfi C J Cardiovasc Med (Hagerstown); 2020 May; 21(5):345-348. PubMed ID: 32141974 [No Abstract] [Full Text] [Related]
16. Transcatheter aortic valve implantation: the transaortic approach. Chow SC; Cheung GS; Lee AP; Wu EB; Ho JY; Kwok MW; Yu PS; Wan IY; Underwood MJ; Wong RH Asian Cardiovasc Thorac Ann; 2017 Jun; 25(5):357-363. PubMed ID: 28513189 [TBL] [Abstract][Full Text] [Related]